Erratum: Effect of intravascular ultrasound-guided vs angiography-guided everolimus-eluting stent implantation: The IVUS-XPL randomized clinical trial (Journal of the American Medical Association (2015) 314:20 (2155-2163) DOI: 10.1001/jama.2015.15454);Effect of intravascular ultrasound-guided vs angiography- guided everolimus-eluting stent implantation: The IVUS-XPL randomized clinical trial

JAMA - Journal of the American Medical Association

Volumn 314, Issue 20, 2015, Pages 2155-2163

  Hong, Sung Jin ^a,b   Kim, Byeong Keuk ^b   Shin, Dong Ho ^b   Nam, Chung Mo ^c   Kim, Jung Sun ^b   Ko, Young Guk ^b   Choi, Donghoon ^b   Kang, Tae Soo ^d   Kang, Woong Chol ^e   Her, Ae Young ^f   Kim, Yonghoon ^f   Hur, Seung Ho ^g   Hong, Bum Kee ^h   Kwon, Hyuckmoon ^h   Jang, Yangsoo ^b,c   Hong, Myeong Ki ^b,c,i   Yang, Joo Young ^z   Cheon, Dong Woon ^z   Lee, Seung Whan ^z   Kim, Byung Ok ^z   Ahn, Chul Min ^z   Chang, Hyuck Jai ^z   Choi, Seong Hoon ^z   Cho, Deok Kyu ^z   Choi, Eui Young ^z   Shim, Ji Young ^z   Yoon, Se Jung ^z   Kim, Jang Young ^z   Lee, Sang Gon ^j   Yoon, Jung Han ^k,l   Jeon, Dong Woon ^m,n   Cho, Yun Hyeong ^o   Choi, Jae Woong ^p   Rhee, Sang Jae ^q   Choi, Rak Kyeong ^r   Lee, Sung Yoon ^a   Kim, Won Ho ^s,t   Lee, Nam Ho ^u,v   Hong, Young Joon ^w   Choi, Hyun Hee ^u   Park, Jong Pil ^x   Lim, Sang Wook ^y   more..

^a Inje University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d Dankook University College of Medicine   (South Korea)

^e Gachon University   (South Korea)

^f Kangwon National University College of Medicine   (South Korea)

^g Keimyung University   (South Korea)

^h Yonsei University College of Medicine   (South Korea)

ⁱ GSH   (South Korea)

^j University of Ulsan College of Medicine   (South Korea)

^k Wonju Severance Christian Hospital   (South Korea)

^l GGUH   (South Korea)

^m DUH   (South Korea)

ⁿ National Health Insurance Corporation   (South Korea)

^o Seonam University of Medicine Myongji Hospital   (South Korea)

^p Eulji General Hospital   (South Korea)

^q Wonkwang University Hospital   (South Korea)

^r Sejong General Hospital   (South Korea)

^s KUDH   (South Korea)

^t Eulji University   (South Korea)

^u Hallym University   (South Korea)

^v KNUH   (South Korea)

^w Chonnam National University   (South Korea)

^x Jeonnju Presbyterian Medical Center   (South Korea)

^y CHA University   (South Korea)

^z Hallym University Chunchun Scared Hospital ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; EVEROLIMUS; IMMUNOSUPPRESSIVE AGENT;

ADULT; ANGIOGRAPHY; ANGIOGRAPHY GUIDED EVEROLIMUS ELUTING CORONARY STENT IMPLANTATION; ANTICOAGULANT THERAPY; ARTICLE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; EVEROLIMUS ELUTING CORONARY STENT; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INTENTION TO TREAT ANALYSIS; INTERMETHOD COMPARISON; INTRAVASCULAR ULTRASOUND; INTRAVASCULAR ULTRASOUND GUIDED EVEROLIMUS ELUTING CORONARY STENT IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TREATMENT RESPONSE; ADVERSE EFFECTS; AGED; ANGIOCARDIOGRAPHY; CLINICAL TRIAL; DRUG ELUTING STENT; ENDOSCOPIC ECHOGRAPHY; ENDOVASCULAR SURGERY; INTERVENTIONAL RADIOLOGY; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; PROCEDURES; PROSTHESIS IMPLANTATION;

AGED; CORONARY ANGIOGRAPHY; DRUG-ELUTING STENTS; ENDOVASCULAR PROCEDURES; EVEROLIMUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROSTHESIS IMPLANTATION; RADIOGRAPHY, INTERVENTIONAL; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84948162604     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2015.18563     Document Type: Erratum

References (34)

1. Stone GW, Ellis SG, Cannon L, et al; TAXUS V Investigators. Comparison of a polymer-based paclitaxel-eluting stent with a baremetal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA. 2005;294(10): 1215-1223.
2. Stone GW, Ellis SG, Cox DA, et al; TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350(3):221-231.
3. Kastrati A, Dibra A, Mehilli J, et al. Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents. Circulation. 2006;113(19):2293-2300.
4. Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007;369 (9562):667-678.
5. Hong MK, Mintz GS, Lee CW, et al. Intravascular ultrasound predictors of angiographic restenosis after sirolimus-eluting stent implantation. Eur Heart J. 2006;27(11):1305-1310.
6. Fujii K, Mintz GS, Kobayashi Y, et al. Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis. Circulation. 2004;109(9):1085-1088.
7. Fujii K, Carlier SG, Mintz GS, et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J AmColl Cardiol. 2005;45(7):995-998.
8. Zhang Y, Farooq V, Garcia-Garcia HM, et al. Comparison of intravascular ultrasound versus angiography-guided drug-eluting stent implantation: ameta-analysis of one randomised trial and ten observational studies involving 19, 619 patients. EuroIntervention. 2012;8(7):855-865.
9. Klersy C, Ferlini M, Raisaro A, et al. Use of IVUS guided coronary stenting with drug eluting stent: a systematic review and meta-analysis of randomized controlled clinical trials and high quality observational studies. Int J Cardiol. 2013;170 (1):54-63.
10. Jang JS, Song YJ, Kang W, et al. Intravascular ultrasound-guided implantation of drug-eluting stents to improve outcome: ameta-analysis. JACC Cardiovasc Interv. 2014;7(3):233-243.
11. Ahn JM, Kang SJ, Yoon SH, et al.Meta-analysis of outcomes after intravascular ultrasound-guided versus angiography-guided drug-eluting stent implantation in 26, 503 patients enrolled in three randomized trials and 14 observational studies. Am J Cardiol. 2014;113(8):1338-1347.
12. Jakabcin J, Spacek R, Bystron M, et al. Long-term health outcome and mortality evaluation after invasive coronary treatment using drug eluting stents with or without the IVUS guidance: randomized control trial: HOME DES IVUS. Catheter Cardiovasc Interv. 2010;75(4):578-583.
13. Chieffo A, Latib A, Caussin C, et al. A prospective, randomized trial of intravascular-ultrasound guided compared to angiography guided stent implantation in complex coronary lesions: the AVIO trial. Am Heart J. 2013; 165(1):65-72.
14. Kim JS, Kang TS, Mintz GS, et al. Randomized comparison of clinical outcomes between intravascular ultrasound and angiography-guided drug-eluting stent implantation for long coronary artery stenoses. JACC Cardiovasc Interv. 2013;6(4): 369-376.
15. Windecker S, Kolh P, Alfonso F, et al; Authors/Task Force members. 2014 ESC/EACTS Guidelines onmyocardial revascularization: the Task Force onMyocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35(37):2541-2619.
16. Cho S, Shin DH, Kim JS, et al. Rationale and design: impact of intravascular ultrasound guidance on long-term clinical outcomes of everolimus-eluting stents in long coronary lesions. Contemp Clin Trials. 2015;40:90-94.
17. Cutlip DE, Windecker S, Mehran R, et al; Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115(17):2344-2351.
18. Thygesen K, Alpert JS, Jaffe AS, et al; Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition ofMyocardial Infarction. Third universal definition ofmyocardial infarction. Circulation. 2012;126(16):2020-2035.
19. Moussa ID, Klein LW, Shah B, et al. Consideration of a new definition of clinically relevantmyocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI). J AmColl Cardiol. 2013;62 (17):1563-1570.
20. Mauri L, Hsieh WH, Massaro JM, Ho KK, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med. 2007;356(10):1020-1029.
21. Mintz GS, Nissen SE, Anderson WD, et al. American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS): a report of the American College of Cardiology task force on clinical expert consensus documents. J AmColl Cardiol. 2001;37 (5):1478-1492.
22. Turco MA, Ormiston JA, Popma JJ, et al. Reduced risk of restenosis in small vessels and reduced risk ofmyocardial infarction in long lesions with the new thin-strut TAXUS Liberté stent: 1-year results from the TAXUS ATLAS program. JACC Cardiovasc Interv. 2008;1(6):699-709.
23. Kim YH, Park SW, Lee SW, et al; Long-DES-II Study Investigators. Sirolimus-eluting stent versus paclitaxel-eluting stent for patients with long coronary artery disease. Circulation. 2006;114(20): 2148-2153.
24. Park DW, Kim YH, Song HG, et al. Comparison of everolimus- and sirolimus-eluting stents in patients with long coronary artery lesions: a randomized LONG-DES-III (Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III) Trial. JACC Cardiovasc Interv. 2011;4(10):1096-1103.
25. Claessen BE, Smits PC, Kereiakes DJ, et al. Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) randomized trials. JACC Cardiovasc Interv. 2011;4 (11):1209-1215.
26. Naidu SS, Krucoff MW, Rutledge DR, et al. Contemporary incidence and predictors of stent thrombosis and other major adverse cardiac events in the year after XIENCE V implantation: results from the 8, 061-patient XIENCE V United States study. JACC Cardiovasc Interv. 2012;5(6):626-635.
27. Oemrawsingh PV, Mintz GS, Schalij MJ, Zwinderman AH, Jukema JW, van derWall EE; TULIP Study. Thrombocyte activity evaluation and effects of Ultrasound guidance in Long Intracoronary stent Placement. Intravascular ultrasound guidance improves angiographic and clinical outcome of stent implantation for long coronary artery stenoses: final results of a randomized comparison with angiographic guidance (TULIP Study). Circulation. 2003;107(1): 62-67.
28. Hong SJ, Kim MH, Ahn TH, et al. Multiple predictors of coronary restenosis after drug-eluting stent implantation in patients with diabetes. Heart. 2006;92(8):1119-1124.
29. Tian NL, Gami SK, Ye F, et al. Angiographic and clinical comparisons of intravascular ultrasoundversus angiography-guided drug-eluting stent implantation for patients with chronic total occlusion lesions: two-year results from a randomised AIR-CTO study. EuroIntervention. 2015; 10(12):1409-1417.
30. Witzenbichler B, Maehara A, Weisz G, et al. Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study. Circulation. 2014;129(4):463-470.
31. Kim JS, Hong MK, Ko YG, et al. Impact of intravascular ultrasound guidance on long-term clinical outcomes in patients treated with drug-eluting stent for bifurcation lesions: data from a Korean multicenter bifurcation registry. Am Heart J. 2011;161(1):180-187.
32. Park SJ, Kim YH, Park DW, et al; MAIN-COMPARE Investigators. Impact of intravascular ultrasound guidance on long-term mortality in stenting for unprotected left main coronary artery stenosis. Circ Cardiovasc Interv. 2009;2(3):167-177.
33. Kim JS, Kim JH, Shin DH, et al. Serial randomized comparison of strut coverage of everolimus- and first-generation sirolimus-eluting stents. Can J Cardiol. 2015;31(6):723-730.
34. Palmerini T, Biondi-Zoccai G, Della Riva D, et al. Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. Lancet. 2012;379(9824):1393-1402.